Beijing Health Guard Biotechnology, Inc
5 clinical trials · Sponsor
◉ Watch Beijing Health Guard Biotechnology, Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine (NCT06207175) | Beijing Health Guard Biotechnology, Inc | 2023-11-21 |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China (NCT05662020) | Beijing Health Guard Biotechnology, Inc | 2022-03-23 |
| A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine (NCT05668572) | Beijing Health Guard Biotechnology, Inc | 2020-12-05 |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine (NCT05694728) | Beijing Health Guard Biotechnology, Inc | 2020-05-23 |
| A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine (NCT05680454) | Beijing Health Guard Biotechnology, Inc | 2019-09-01 |
Track Beijing Health Guard Biotechnology, Inc automatically
Every clearance here is in the API, with alerts when new ones post.